| Ytd | -63.54% | |
| 1y | -35.98% |
| Open | 1.04 | Prev Close | 1.04 | Low | 1.03 | High | 1.05 | Mkt Cap | 17.91M |
| Vol | 3.02K | Avg Vol | 36.32K | EPS | 0.14 | P/E | 7.50 | Forward P/E | N/A |
| Beta | 0.46 | Short Ratio | 3.42 | Inst. Own | 0.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.31 | 200-d Avg | 1.82 | 1yr Est | 0.00 |
BCG News
Binah Capital Group (NASDAQ: BCG - Get Free Report) and Hennessy Advisors (NASDAQ: HNNA - Get Free R
PennantPark Investment (NASDAQ: PNNT - Get Free Report) and Binah Capital Group (NASDAQ: BCG - Get F
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the Europea
ZURICH--(BUSINESS WIRE)--ABB today published a new report, The Strategic Case for Hybrid AC/DC Power
New ABB and BCG report highlights growing role of direct current technologies in future power system
- Assets Under Management (“AuM”) Increased 13.4% Year-over-Year to $31.6 Billion - - Increased Net
NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Binah Capital Group, Inc. (“Binah”, “Binah Capital” or t
Christoph Schweizer, CEO of Boston Consulting Group (BCG), tells CNBC's Squawk Box Europe that AI ad
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-vi
SAN FRANCISCO--(BUSINESS WIRE)--Transcend, the autonomous "can I use this data?" platform that power
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (
AstraZeneca's IMFINZIÂ (durvalumab) in combination with Bacillus Calmette-GuÃrin (BCG) induction and
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca's IMFINZI® (durvalumab) in combination with Bacillus
TVS Motor Company, part of TVS VENU, has been ranked #1 globally in the âDurable Consumer Goods' c
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today annou
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a vertically integrated commercial-stage immunotherap
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a vertically integrated commercial-stage immunotherap
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today annou
- Assets Under Management (“AuM”) Increased 12.9% Year-over-Year to $29.0 Billion - - Increased Net
- High CR rates at any time observed in the CIS-containing population with 85.7% and 92.3% in the IT
Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 result
Binah Capital surged 59.20% in after-hours trading on strong fourth-quarter and full-year results, p
Binah Capital Group (NASDAQ:BCG) reported quarterly earnings of $0.01 per share. This is a 114.29 pe
BNO, USO: ~1.5% | Oil is trading higher amid reports of Iran seizing an oil tanker in the Strait of
Binah Capital jumped 74.76% in after-hours trading following stronger-than-expected Q3 results.
Binah Capital Group (NASDAQ:BCG) reported quarterly earnings of $0.08 per share. This is a 188.89 pe